Alvotech (ALVO) Stock Highlights

11.91 | -1.65%

2024-12-21 02:38:32

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. The companys purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Statistics

Range Today

11.7 12

Volume Today 1.2M

Range 1 Year

9.15 18

Volume 1 Year 43.17M

Range 3 Year

5.2 18

Volume 3 Year 72.48M

Range 10 Year

5.2 18

Volume 10 Year 72.48M

Highlights

Market Capitalization 3.83B (mid)

Floating Shares 98.74M

Current Price 11.91

Price To Earnings -4.77

Price To Revenue 15.27

Earnings Per Share -2.65

Payout Ratio 0%

Performance

Latest -1.65%

1 Month -4.64%

3 Months +6.43%

6 Months -11.78%

1 Year +10.79%

3 Years +25.37%

5 Years +25.37%

10 Years +25.37%

Benchmarks

Market Capitalization

7 / 54

Gross Profits

34 / 39

Total Revenue

40 / 50

Total Rank

26 / 54

Free Cashflow

53 / 54

Performance 5 years

11 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.